Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864 in a conflict situation in the ratMIZOULE, J; GAUTHIER, A; UZAN, A et al.Life sciences (1973). 1985, Vol 36, Num 11, pp 1059-1068, issn 0024-3205Article

Differential effect of detergents on [³H] Ro-4864 and [³H] PK 11195 binding to peripheral-type benzodiazepine-binding sitesAWAD, M; GAVISH, M.Life sciences (1973). 1988, Vol 43, Num 2, pp 167-175, issn 0024-3205Article

Binding sites for a peripheral type benzodiazepine antagonist ([³H] PK 11195) in human irisVALTIER, D; MALGOURIS, C; GILBERT, J.-C et al.Neuropharmacology. 1987, Vol 26, Num 6, pp 549-552, issn 0028-3908Article

Peripheral benzodiazepine receptors on platelets in chronic and detoxified alcoholicsKARP, L; WEIZMAN, A; FLIMAN, M et al.Neuropharmacology. 1991, Vol 30, Num 6, pp 665-669, issn 0028-3908, 5 p.Article

PK 11195, an antagonist of peripheral type benzodiazepine receptors, modulates bay K8644 sensitive but not β- or H₂-receptor sensitive voltage operated calcium channels in the guinea pig heartMESTRE, M; CARRIOT, T; NELIAT, G et al.Life sciences (1973). 1986, Vol 39, Num 4, pp 329-339, issn 0024-3205Article

Benzodiazepine receptor-mediated chemotaxis of human monocytesRUFF, M. R; PERT, C. B; WEBER, R. J et al.Science (Washington, D.C.). 1985, Vol 229, Num 4719, pp 1281-1283, issn 0036-8075Article

Carbamazepine up-regulates the binding of [³H]PK 11195 to platelets of epileptic patientsWEIZMAN, A; TANNE, Z; KARP, L et al.European journal of pharmacology. 1987, Vol 141, Num 3, pp 471-474, issn 0014-2999Article

Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [³H]PK 11195BENAVIDES, J; SAVAKI, H. E; GUEREMY, C et al.Brain research bulletin. 1984, Vol 13, Num 1, pp 69-77, issn 0361-9230Article

Attenuation of ammonia toxicity in mice by PK 11195 and pregnenolone sulfateITZHAK, Y; NORENBERG, M. D.Neuroscience letters. 1994, Vol 182, Num 2, pp 251-254, issn 0304-3940Article

Absence d'effet anti-ischémique d'un antagoniste des récepteurs périphériques aux benzodiazépines PK 11195: étude par stimulation atriale chez l'homme = Absence of anti-ischemic effects of a peripheral benzodiazepine receptor antagonist PK 11195. Assessment with atrial pacing in manDROBINSKI, G; LECHAT, P; EUGENE, L et al.Thérapie (Paris). 1989, Vol 44, Num 4, pp 263-267, issn 0040-5957Article

Species differences and heterogeneity of solubilized peripheral-type benzodiazepine binding sitesMOHAMED AWAD; MOSHE GAVISH.Biochemical pharmacology. 1989, Vol 38, Num 21, pp 3843-3849, issn 0006-2952Article

In vivo immunomodulating activity of PK11195, a structurally unrelated ligand for peripheral benzodiazepine binding sites. The possible involvement of central cervous system receptorsLENFANT, M; HAUMONT, J; HORAK, P et al.International journal of immunotherapy. 1988, Vol 4, Num 2, pp 125-129, issn 0255-9625Article

Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomyBASILE, A. S; OSTROWSKI, N. L; SKOLNICK, P et al.The Journal of pharmacology and experimental therapeutics. 1987, Vol 240, Num 3, pp 1006-1013, issn 0022-3565Article

Lack of effect of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenicsTANNE, Z; WEIZMAN, R; KARP, L et al.Neuropsychobiology. 1987, Vol 17, Num 3, pp 121-123, issn 0302-282XArticle

Increased peripheral benzodiazepine receptors in arterial plaque of patients with atherosclerosis : An autoradiographic study with [³H]PK 11195FUJIMURA, Yota; HWANG, Paul M; TROUT, Hugh et al.Atherosclerosis. 2008, Vol 201, Num 1, pp 108-111, issn 0021-9150, 4 p.Article

In vitro quantitative autoradiography of [³H]-L-deprenyl and [³H]-PK 11195 binding sites in human epileptic hippocampusKUMLIEN, E; HILTON-BROWN, P; SPÄNNARE, B et al.Epilepsia (Copenhagen). 1992, Vol 33, Num 4, pp 610-617, issn 0013-9580Article

Relaxation of rat vascular muscle by peripheral benzodiazepine modulatorsEME, P; CHIESI, M; LONGONI, S et al.The Journal of clinical investigation. 1989, Vol 84, Num 2, pp 493-498, issn 0021-9738Article

Peripheral benzodiazepines enhance the respiratory burst of macrophage-like P388D₁ cells stimulated by arachidomic acidZAVALA, F; LENFANT, M.International journal of immunopharmacology. 1987, Vol 9, Num 3, pp 269-274, issn 0192-0561Article

Dissimilarities between benzodiazepine-binding sites and adenosine uptakes sites in astrocytes and neurons in primary culturesBENDER, A. S; HERTZ, L.Journal of neuroscience research. 1987, Vol 17, Num 2, pp 154-161, issn 0360-4012Article

Differential sensitivity of central and peripheral type benzodiazepine receptors to phospholipase A₂HAVOUNDJIAN, H; COHEN, R. M; PAUL, S. M et al.Journal of neurochemistry. 1986, Vol 46, Num 3, pp 804-811, issn 0022-3042Article

Functional characterization and expression of PBR in rat gastric mucosa: stimulation of chloride secretion by PBR ligandsOSTUNI, M. A; MARAZOVA, K; PERANZI, G et al.American journal of physiology. Gastrointestinal and liver physiology. 2004, Vol 49, Num 6, pp G1069-G1080, issn 0193-1857Article

PET of peripheral benzodiazepine binding sites in the microgliosis in Alzheimer's diseaseGROOM, G. N; JUNCK, L; FOSTER, N. L et al.The Journal of nuclear medicine (1978). 1995, Vol 36, Num 12, pp 2207-2210, issn 0161-5505Article

The effects of the peripheral-type benzodiazepine acceptor ligands, Ro 5-4864 and PK 11195, on mitochondrial respirationZISTERER, D. M; GORMAN, A. M. C; WILLIAMS, D. C et al.Methods and findings in experimental and clinical pharmacology. 1992, Vol 14, Num 2, pp 85-90, issn 0379-0355Article

Differential binding properties of the peripheral-type benzodiazepine ligands [³H]PK 11195 and [³H]Ro 5-4864 in trout and mouse brain membranesESHLEMAN, A. J; MURRAY, T. F.Journal of neurochemistry. 1989, Vol 53, Num 2, pp 494-502, issn 0022-3042Article

Variation chez l'homme de l'excrétion du 6-β-hydroxycortisol urinaire après administration d'un nouveau dérivé de l'isoquinoléine, PK-11195 (52028 RP) = Urine excretion of 6-β-hydroxycortisol in human, after administration of a new drug, an isoquinoline derivativeFRECHE, J. P; DECOLIN, D; SIEST, J. P et al.Thérapie (Paris). 1989, Vol 44, Num 5, pp 327-330, issn 0040-5957Article